Bipolar Disorder (2018) |
1.54 |
3 |
0 |
0.0 |
-0.97 |
2.5e-02 |
AC103965.1 LOC147727 ZSCAN2 |
Bipolar Disorder or Schizophrenia |
1.89 |
8 |
3 |
6.7 |
-0.51 |
1.3e-01 |
AC103965.1 GOLGA6L4 GOLGA6L5 PCDHB5 PSMA4 TRIM38 U91328.21 ZSCAN2 |
Depressed Affect (Nagel 2018) |
2.04 |
6 |
4 |
8.9 |
-0.68 |
1.4e-01 |
C1QTNF4 LRRC37A LRRC37A2 RP11-196G11.2 RP11-669E14.6 WNT3 |
Depression (Nagel 2018) |
1.53 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
WNT3 |
Intelligence (Savage-Jansen 2018) |
1.80 |
14 |
9 |
20.0 |
0.90 |
9.1e-07 |
ACP2 ARL17A C1QTNF4 CENPW CTNNB1 DCAF16 DLEU2 NSFP1 PCDHB5 PPA2 RNF123 TULP4 UBXN2A WNT3 |
Neuroticism (Nagel 2018) |
2.34 |
11 |
7 |
15.6 |
-0.68 |
2.1e-02 |
ARL17A C1QTNF4 CENPW FBXO38 LRRC37A LRRC37A2 NSFP1 RP11-196G11.2 RP11-669E14.6 U91328.21 WNT3 |
Schizophrenia (2018) |
1.69 |
6 |
3 |
6.7 |
-0.44 |
2.8e-01 |
AC103965.1 PCDHB5 PSMA4 TRIM38 U91328.21 ZSCAN2 |
Worry (Nagel 2018) |
1.92 |
9 |
5 |
11.1 |
-0.84 |
5.0e-03 |
ARL17A CENPW FBXO38 LRRC37A LRRC37A2 NSFP1 RP11-196G11.2 RP11-669E14.6 WNT3 |
Alzheimer’s Disease (including proxy) |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-196G11.2 |
Crohns Disease (2017) |
1.35 |
5 |
4 |
8.9 |
0.29 |
6.4e-01 |
ADCY3 ADO SLC22A4 TPD52L2 ZBTB38 |
Irritable Bowel Disease (IBD) |
1.27 |
5 |
3 |
6.7 |
0.00 |
1.0e+00 |
ADCY3 ADO CTSS SLC22A4 TPD52L2 |
Ulcerative Colitis (UC) |
1.10 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
RNF123 SLC22A4 |
Reaction Time |
1.72 |
4 |
2 |
4.4 |
-0.94 |
5.7e-02 |
ARL17A LOC147727 NSFP1 SCUBE2 |
Verbal and Numeric Reasoning (VNR) |
2.00 |
8 |
6 |
13.3 |
0.67 |
2.3e-02 |
C1QTNF4 CENPW DCAF16 PPA2 RNF123 TULP4 U91328.21 UBXN2A |
Breast Cancer |
1.57 |
9 |
8 |
17.8 |
-0.48 |
1.9e-01 |
ADCY3 LRRC37A LRRC37A2 RIN3 RP11-669E14.6 RP11-73O6.3 SLC22A4 WNT3 ZBTB38 |
Ovarian Cancer |
1.70 |
5 |
4 |
8.9 |
0.81 |
9.8e-02 |
DNALI1 LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Prostate Cancer |
1.58 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
MDM4 |
Age at First Birth |
1.04 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ABHD12 |
Body Mass Index (BMI) (2010) |
1.89 |
4 |
2 |
4.4 |
-0.99 |
3.7e-05 |
ACP2 ADCY3 C1QTNF4 PSMC3 |
Crohns Disease (2012) |
1.49 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ADO SLC22A4 TPD52L2 |
HDL Cholesterol |
2.23 |
5 |
4 |
8.9 |
0.81 |
1.5e-02 |
ACP2 ARHGAP1 C1QTNF4 C6orf106 PSMC3 |
LDL Cholesterol |
1.22 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CACFD1 LOC147727 |
Lupus |
1.47 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZNF76 |
Neuroticism (2016) |
1.88 |
4 |
3 |
6.7 |
-0.74 |
2.6e-01 |
FAM66A LRRC37A2 RP11-669E14.6 WNT3 |
Primary Biliary Cirrhosis |
1.71 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A RP11-669E14.6 WNT3 |
Schizophrenia (2014) |
1.48 |
3 |
1 |
2.2 |
-0.99 |
1.3e-02 |
AC103965.1 GOLGA6L5 H1FX |
Triglycerides |
1.27 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
FAM66A RP11-196G11.2 |
Blood Eosinophil Count |
1.95 |
34 |
22 |
48.9 |
-0.30 |
6.3e-02 |
AC103965.1 AHI1 ARL17A C4orf14 C5orf34 CACFD1 CNPY2 CTSS DLEU2 EBPL FAM136A FAM26F GSK3A HTR4 KIAA1614 LRRC37A LRRC37A2 MAPK13 NOB1 NOSTRIN PCGF2 RAB5B RIN3 RP11-669E14.6 RP11-73O6.3 RPL10A SEC24C SLC22A4 SMPD2 TRIM63 TSPY26P WNT3 ZNF76 ZSCAN2 |
Blood Platelet Count |
1.46 |
41 |
30 |
66.7 |
-0.35 |
1.8e-02 |
ABHD12 AC103965.1 ACP2 ADO ARL17A C1QTNF4 C4orf14 C6orf106 CACFD1 CEP120 CNPY2 CTSS DCAF16 DENND2D FAM136A FER GIPC2 GOLGA6L4 HESX1 HTR4 KIAA1614 LOC147727 LRRC37A LRRC37A2 NSFP1 OTUD4 PNKD PPA2 PSMC3 RIN3 RP11-669E14.6 SCMH1 SLC22A4 SLMAP SMARCD2 SMPD2 TPD52L2 TULP4 ZCCHC24 ZHX2 ZSCAN2 |
Blood Red Count |
2.18 |
27 |
19 |
42.2 |
-0.34 |
6.7e-02 |
AC103965.1 AOC1 ASPSCR1 C6orf106 CACFD1 CCDC87 CD79B CENPW COQ10A DARS FAM136A LRRC37A LRRC37A2 MST1P2 NFAT5 NOB1 PAN2 PSMC5 RAD9A RP11-196G11.2 RP11-669E14.6 RP11-73O6.3 RP11-977G19.11 SMPD2 SNAI3-AS1 WNT3 ZBTB38 |
Blood White Count |
2.05 |
39 |
28 |
62.2 |
-0.60 |
6.9e-06 |
ACP2 ADO AHI1 C1QTNF4 C4orf14 C5orf34 C6orf106 CACFD1 CENPW CEP120 CTB-36H16.2 DCAF16 EBPL FBXO38 FER GM2A GSK3A HTR4 KIAA1614 LRRC37A MICAL3 NOB1 NOSTRIN PCDHB5 PNKD PSMC3 RIN3 RP11-669E14.6 RP11-73O6.3 SCMH1 SCUBE3 SLC22A4 SMARCD2 SMPD2 TRA2A TULP4 UBXN2A ZHX2 ZNF76 |
Heel T-Score |
3.22 |
53 |
39 |
86.7 |
-0.03 |
8.2e-01 |
AC103965.1 ACP2 ADCY3 ARHGAP1 ARL17A ASPSCR1 C4orf14 CACFD1 CDKN2C CEP120 CRIPAK CTA-85E5.10 CTB-36H16.2 CTNNB1 CTSS DCAF16 DIRAS3 DLEU2 EBPL EEF1G FHL3 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 JAG1 KIAA1614 LRRC37A LRRC37A2 NSFP1 PLEKHM1P PSMC3 RAB24 RP11-196G11.2 RP11-669E14.6 RP11-73O6.3 RP11-967K21.1 RPL10A SAPS3 SCMH1 SLMAP SMARCD2 SNAI3-AS1 THSD4 TULP4 WHAMM WNT3 WNT4 ZBTB38 ZCCHC24 ZNF438 ZNF76 |
BMI |
2.19 |
31 |
19 |
42.2 |
-0.38 |
2.0e-02 |
ACP2 ADCY3 AP3B1 ARFGEF2 C1QTNF4 C6orf106 CEP120 CTNNB1 DCAF16 GIPC2 GSDMC GSK3A HTR4 IGHMBP2 LOXL1-AS1 MST1P2 NFAT5 NOB1 OTUD4 PSMC3 RAB24 RAB5B RNF123 RP11-196G11.2 RP11-538P18.2 RP11-73O6.3 SAPS3 SMARCD2 TMED6 TSPY26P ZNF500 |
Height |
9.96 |
124 |
115 |
255.6 |
0.88 |
2.5e-46 |
AC083843.1 AC103965.1 ACP2 ADCY3 ADO AHI1 AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK C10orf11 C1QTNF4 C4orf14 C6orf106 C6orf126 CACFD1 CCDC87 CD79B CDC123 CDKN2C CDO1 CENPW CEP120 CLUAP1 CNPY2 COQ10A CRIPAK CTA-85E5.10 CTC-542B22.2 CTD-3076O17.1 CTNNB1 CTSS CYB561 DCAF16 DHDDS DIRAS3 DLEU2 DNAJC9-AS1 DNALI1 EBPL EFEMP1 ERCC6L2 FAM136A FAM26F FER FHL3 GDF5 GIPC2 GOLGA6L4 GOLGA6L5 GSDMC GSK3A H1FX H6PD HHIP-AS1 ICAM2 IGHMBP2 IPO8 JAG1 KIAA1614 LOC147727 LOXL1-AS1 LRRC37A LRRC37A2 MAPK13 MDM4 MICAL3 MRPL42 MST1P2 MXD3 NFAT5 NOB1 NOC3L NOSTRIN NSFP1 OTUD4 PAN2 PCDHB5 PLEKHM1P PNKD PPA2 PPIAL4C PSMC3 PSMC5 QSOX2 RAB24 RAD9A RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-967K21.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TMED6 TP53INP2 TPD52L2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 ZSCAN2 |
Waist Hip Ratio (WHR) |
2.59 |
32 |
21 |
46.7 |
-0.45 |
6.4e-03 |
AC103965.1 ADCY3 AP3B1 ASPSCR1 C6orf106 CD79B CENPW CLUAP1 DENND2D DLEU2 EBPL EEF1G GDF5 GIPC2 GOLGA6L5 HHIP-AS1 LOC147727 LRRC37A LRRC37A2 NFAT5 NSFP1 OTUD4 PSMC5 RAB24 RAD9A RP11-669E14.6 RP11-73O6.3 SCUBE2 WNT3 WNT4 ZBTB38 ZSCAN2 |
Systolic Blood Pressure |
1.75 |
31 |
17 |
37.8 |
-0.34 |
5.7e-02 |
ADCY3 ADO ARFGEF2 ARHGAP1 ARL17A C1QTNF4 CARS2 CDC123 CEP120 DCAF16 EFEMP1 FBXO38 FER FHL3 GDF5 GIPC2 HTR4 LRRC37A2 MICAL3 NSFP1 NUDT5 PCDHB5 PLEKHM1P PNKD RIN3 RP11-538P18.2 RP11-669E14.6 RPL10A ZHX2 ZNF500 ZNF76 |
Smoking Status |
1.48 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CNPY2 NOB1 WNT3 |
Allergy or Eczema |
1.56 |
5 |
4 |
8.9 |
-0.62 |
1.9e-01 |
AHI1 C6orf106 RAB5B SLC22A4 ZBTB38 |
Cardiovascular Disease |
1.47 |
12 |
5 |
11.1 |
-0.84 |
3.4e-04 |
ACP2 ADO ARHGAP1 C1GALT1 DCAF16 HTR4 MXD3 RP11-196G11.2 RP11-538P18.2 SLC22A4 SMARCD2 TSPY26P |
Hypothyroidism (self reported) |
1.34 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
AHI1 RAB5B RIN3 |
Respiratory disease |
2.31 |
11 |
6 |
13.3 |
-0.95 |
7.3e-07 |
ADAM19 AHI1 C4orf14 CNPY2 HTR4 RAB5B SCUBE3 SEC24C SLC22A4 TPD52L2 ZNF76 |
Type 2 Diabetes (T2D) (2018) |
1.74 |
5 |
1 |
2.2 |
-0.65 |
2.4e-01 |
C1GALT1 CENPW HTR4 NOB1 NUDT5 |
Lung FEV1/FVC ratio |
8.13 |
63 |
50 |
111.1 |
0.74 |
2.7e-13 |
AC103965.1 ADAM19 ADCY3 ADO BTBD1 C10orf11 C1GALT1 C4orf14 C6orf106 CDC123 CDKN2C CENPW CEP120 CNPY2 CTA-85E5.10 CTC-542B22.2 CTNNB1 DENND2D DNAJC9-AS1 DNALI1 EEF1G EFEMP1 FAM168A FBXO38 GDF5 GIPC2 GM2A GOLGA6L4 GOLGA6L5 GSTCD HESX1 HHIP-AS1 HTR4 LONRF2 LRRC37A LRRC37A2 METAP2 MICAL3 MST1P2 NUDT5 OTUD4 PCGF2 PLEKHM1P PPA2 PSMA4 RAB5B RP11-382A20.2 RP11-669E14.6 RPL10A SCUBE2 SCUBE3 SEC24C SLC22A4 SLMAP SMPD2 SOGA2 SYNM THSD4 TSPY26P WHAMM ZBTB38 ZNF76 ZSCAN2 |
Lung FVC |
6.80 |
102 |
75 |
166.7 |
0.87 |
6.9e-33 |
ABHD12 AC073834.3 ACP2 AHI1 ANGPTL1 AOC1 AP3B1 ARFGEF2 ARL17A ASPSCR1 BOK BTBD1 C10orf11 C1GALT1 C4orf14 C5orf34 C6orf106 C6orf126 CACFD1 CCDC87 CD79B CDC123 CENPW CEP120 CLUAP1 CTA-85E5.10 CTB-36H16.2 CTSS DARS DCAF16 DHDDS DIRAS3 EBPL EEF1G EFEMP1 FAM136A FAM26F FBXO38 GALNT12 GDF5 GM2A GSDMC GSK3A GSTCD HTR4 IGHMBP2 IPO8 JAG1 KIAA1614 LONRF2 LRPAP1 LRRC37A LRRC37A2 MAPK13 MDM4 MICAL3 MST1P2 NFAT5 NOB1 NSFP1 NUDT5 PCDHB5 PLEKHM1P PPA2 PPIAL4C PSMA4 PSMC5 QSOX2 RAB5B RAD9A RIN3 RNF123 RP11-196G11.2 RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-73O6.3 RP11-78I14.1 RP11-967K21.1 RPL10A SAPS3 SCMH1 SEC24C SLC22A4 SLMAP SMPD2 SNAI3-AS1 SOGA2 TCP11L1 THSD4 TPD52L2 TRIM63 TSPY26P TULP4 UBXN2A WHAMM WNT3 WNT4 ZBTB38 ZNF438 ZNF76 |
Neuroticism |
2.23 |
10 |
6 |
13.3 |
-0.73 |
1.6e-02 |
ARL17A C1QTNF4 CENPW FBXO38 LRRC37A LRRC37A2 NSFP1 RP11-196G11.2 RP11-669E14.6 WNT3 |
Chronotype (morning person) |
1.46 |
6 |
0 |
0.0 |
-1.00 |
4.0e-06 |
ACP2 C1QTNF4 CRIPAK CTSS CYB561 LOC147727 |
Hair Pigment |
0.70 |
21 |
16 |
35.6 |
0.15 |
5.0e-01 |
ACP2 ARHGAP1 ASPSCR1 BTBD1 C1QTNF4 C4orf14 CCDC87 FAM136A GDF5 IGHMBP2 LOC147727 LRRC37A LRRC37A2 RP11-669E14.6 RP11-73O6.3 SAPS3 SNAI3-AS1 TP53INP2 TULP4 ZBTB38 ZNF76 |
Tanning |
0.82 |
9 |
8 |
17.8 |
0.38 |
3.1e-01 |
ADCY3 ADO CTSS GDF5 MAPK13 METAP2 MXD3 SNAI3-AS1 TP53INP2 |
Hand grip strength (left) |
4.13 |
34 |
21 |
46.7 |
0.97 |
9.7e-23 |
ACP2 ADCY3 AOC1 ARFGEF2 C1QTNF4 C6orf106 CCDC87 CD79B CRIPAK CYB561 DARS DCAF16 FER GDF5 H1FX IGHMBP2 JAG1 LOXL1-AS1 LRRC37A LRRC37A2 NOB1 PSMC3 PSMC5 RAD9A RP11-250B2.6 RP11-669E14.6 RP11-73O6.3 SAPS3 SLC22A4 TRA2A WNT3 ZBTB38 ZCCHC24 ZNF76 |
Number of treatments/medications taken |
1.43 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
DCAF16 |
Sensitivity / hurt feelings |
2.22 |
5 |
4 |
8.9 |
-1.00 |
1.5e-04 |
ARL17A LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Frequency of depressed mood in last 2 weeks |
1.52 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
WNT3 |
Relative age of first facial hair |
2.42 |
6 |
5 |
11.1 |
-0.78 |
4.0e-02 |
C6orf106 LRRC37A LRRC37A2 RP11-669E14.6 WNT3 ZBTB38 |
Systolic blood pressure, automated reading |
2.17 |
21 |
7 |
15.6 |
-0.48 |
2.9e-02 |
ADCY3 ADO ARHGAP1 DCAF16 EFEMP1 ERI1 FAM66A FBXO38 FER FHL3 HTR4 LRRC37A2 NSFP1 NUDT5 PPA2 RP11-538P18.2 RP11-669E14.6 RPL10A U91328.21 ZHX2 ZNF76 |
Medication: Metformin |
1.70 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C1QTNF4 NUDT5 |
Diabetes (mother) |
1.52 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
NUDT5 |
Pack years adult smoking proportion |
2.51 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CYB561 PSMA4 |
Impedance of leg (right) |
2.90 |
35 |
23 |
51.1 |
0.12 |
4.9e-01 |
AC103965.1 ADCY3 AOC1 AP3B1 C1QTNF4 C5orf34 C6orf106 CD79B CDO1 CEP120 CTD-3076O17.1 CTSS ERI1 FAM66A GDF5 GOLGA6L4 GOLGA6L5 H1FX IGHMBP2 LOXL1-AS1 MST1P2 OTUD4 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-382A20.2 RP11-669E14.6 RP11-73O6.3 SAPS3 SMPD2 SNAI3-AS1 WNT4 ZSCAN2 |
Leg fat-free mass (left) |
5.38 |
60 |
49 |
108.9 |
0.89 |
9.9e-25 |
AC083843.1 AOC1 AP3B1 BOK C6orf106 CD79B CDKN2C CENPW CEP120 CRIPAK CTNNB1 DCAF16 DLEU2 EBPL EFEMP1 ERI1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PNKD PPA2 PSMC5 QSOX2 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZNF500 ZNF76 |
Trunk fat percentage |
3.25 |
36 |
24 |
53.3 |
0.04 |
8.2e-01 |
ABHD12 AC103965.1 ACP2 ADCY3 AP3B1 ARFGEF2 ARL17A C1QTNF4 C6orf106 CENPW CTD-3076O17.1 CTNNB1 DARS EEF1G EFEMP1 GOLGA6L4 GOLGA6L5 HTR4 LRRC37A2 MAPK13 NOB1 NSFP1 OTUD4 PSMC3 PSMC5 RAD9A RIN3 RP11-196G11.2 RP11-669E14.6 RP11-78I14.1 SYNM TPD52L2 WNT3 ZBTB38 ZNF500 ZSCAN2 |
Hand grip strength (right) |
4.09 |
36 |
20 |
44.4 |
0.96 |
4.6e-21 |
ADCY3 ANGPTL1 AOC1 ARFGEF2 C1QTNF4 C6orf106 CD79B CRIPAK CYB561 DARS DCAF16 GDF5 H1FX JAG1 LOXL1-AS1 LRRC37A LRRC37A2 NOB1 NOSTRIN PCGF2 PSMC3 PSMC5 RAD9A RP11-250B2.6 RP11-669E14.6 RP11-73O6.3 SCMH1 SLC22A4 SMARCD2 TP53INP2 TRA2A TULP4 WNT3 ZBTB38 ZCCHC24 ZNF76 |
Current tobacco smoking |
1.37 |
3 |
0 |
0.0 |
0.76 |
2.4e-01 |
C1QTNF4 FAM66A TPD52L2 |
Fed-up feelings |
1.75 |
5 |
4 |
8.9 |
-0.99 |
1.8e-03 |
ARHGAP1 LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Relative age voice broke |
1.85 |
5 |
4 |
8.9 |
-0.99 |
2.0e-03 |
LRRC37A LRRC37A2 RP11-669E14.6 SCMH1 WNT3 |
Taking other prescription medications |
1.28 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM19 AHI1 |
Age when periods started (menarche) |
1.92 |
7 |
4 |
8.9 |
-0.01 |
9.9e-01 |
ADCY3 C1QTNF4 CENPW NFAT5 NOB1 RP11-669E14.6 SCMH1 |
Bilateral oophorectomy (both ovaries removed) |
1.04 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
WNT4 |
Heel bone mineral density (BMD) T-score, automated (left) |
2.58 |
14 |
10 |
22.2 |
-0.27 |
2.9e-01 |
ACP2 ARHGAP1 CRIPAK DLEU2 EBPL ERI1 FAM66A FHL3 HHIP-AS1 IGHMBP2 JAG1 SAPS3 WNT4 ZNF438 |
High blood pressure |
1.84 |
14 |
6 |
13.3 |
-0.86 |
4.8e-05 |
ACP2 ADO ARFGEF2 ARHGAP1 C1GALT1 DCAF16 ERI1 FAM66A HTR4 RP11-196G11.2 RP11-538P18.2 SLC22A4 TSPY26P U91328.21 |
Hayfever, allergic rhinitis or eczema |
1.40 |
5 |
4 |
8.9 |
-0.67 |
1.5e-01 |
AHI1 C6orf106 RAB5B SLC22A4 ZBTB38 |
Medication: Levothyroxine sodium |
1.38 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ERI1 RAB5B |
Sitting height |
8.54 |
98 |
86 |
191.1 |
0.90 |
1.6e-43 |
ABHD12 AC073834.3 AC083843.1 AC103965.1 ACP2 ADCY3 AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK C1QTNF4 C6orf106 CACFD1 CD79B CDKN2C CDO1 CENPW CEP120 COQ10A CRIPAK CTC-542B22.2 CTD-3076O17.1 CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 ERCC6L2 FAM136A FAM26F FHL3 GDF5 GOLGA6L4 GOLGA6L5 GSDMC GSK3A H1FX H6PD HHIP-AS1 ICAM2 IGHMBP2 JAG1 KIAA1614 LOC147727 LOXL1-AS1 LRRC37A LRRC37A2 MRPL42 MST1P2 MXD3 NFAT5 NOB1 NOC3L NOSTRIN OTUD4 PAN2 PCDHB5 PNKD PPA2 PSMC3 PSMC5 QSOX2 RAD9A RP11-250B2.6 RP11-538P18.2 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-967K21.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TMED6 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 ZSCAN2 |
Chronic bronchitis/emphysema (father) |
1.85 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PSMA4 |
Body mass index (BMI) |
2.27 |
25 |
11 |
24.4 |
-0.52 |
4.0e-03 |
ACP2 ADCY3 AP3B1 ARFGEF2 C1QTNF4 C6orf106 CCDC87 CEP120 CTC-542B22.2 DARS DCAF16 ERI1 FAM66A HTR4 IGHMBP2 LOXL1-AS1 MST1P2 NFAT5 NOB1 OTUD4 PSMC3 RAB5B RP11-196G11.2 TMED6 TRIM38 |
Impedance of leg (left) |
2.88 |
36 |
23 |
51.1 |
0.10 |
5.5e-01 |
AC103965.1 ADCY3 AOC1 AP3B1 C1QTNF4 C5orf34 CD79B CDO1 CEP120 CTD-3076O17.1 CTSS ERI1 FAM66A GDF5 GOLGA6L4 GOLGA6L5 H1FX IGHMBP2 LOXL1-AS1 LRRC37A2 MST1P2 OTUD4 PPA2 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-382A20.2 RP11-669E14.6 RP11-73O6.3 SAPS3 SMPD2 WNT3 WNT4 ZSCAN2 |
Leg predicted mass (left) |
5.37 |
60 |
49 |
108.9 |
0.89 |
4.3e-25 |
AC083843.1 AOC1 AP3B1 BOK C6orf106 CD79B CDKN2C CENPW CEP120 CRIPAK CTNNB1 DCAF16 DLEU2 EBPL EFEMP1 ERI1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PLEKHM1P PNKD PPA2 PSMC5 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZNF500 ZNF76 |
Trunk fat mass |
3.39 |
38 |
26 |
57.8 |
0.35 |
2.0e-02 |
ABHD12 AC103965.1 ACP2 ADCY3 AP3B1 ARL17A BOK C1QTNF4 C6orf106 CEP120 CTD-3076O17.1 CTNNB1 DLEU2 EEF1G EFEMP1 GDF5 GOLGA6L4 GOLGA6L5 H1FX HTR4 LRRC37A2 MAPK13 NOB1 NSFP1 OTUD4 PSMC3 RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 SYNM TP53INP2 TPD52L2 TRIM38 WNT3 ZBTB38 ZNF500 ZSCAN2 |
Waist circumference |
2.27 |
21 |
15 |
33.3 |
0.07 |
7.2e-01 |
ABHD12 ACP2 ADCY3 AP3B1 C1QTNF4 C6orf106 CEP120 CTNNB1 GOLGA6L4 HTR4 NOB1 OTUD4 PSMC3 RAD9A RP11-196G11.2 RP11-78I14.1 RPL10A TPD52L2 ZBTB38 ZNF500 ZSCAN2 |
Number of incorrect matches in round |
1.53 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-196G11.2 |
Past tobacco smoking |
1.55 |
4 |
0 |
0.0 |
-0.50 |
5.0e-01 |
C4orf14 CNPY2 NOB1 RP11-977G19.11 |
Nervous feelings |
1.99 |
10 |
5 |
11.1 |
-0.50 |
1.4e-01 |
ARL17A CENPW ERI1 FAM66A FBXO38 LRRC37A LRRC37A2 RP11-196G11.2 RP11-669E14.6 WNT3 |
Frequency of tenseness / restlessness in last 2 weeks |
1.65 |
4 |
3 |
6.7 |
-1.00 |
6.6e-04 |
LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Hearing difficulty/problems with background noise |
1.41 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-669E14.6 |
Hair/balding pattern: Pattern 2 |
2.03 |
5 |
3 |
6.7 |
-0.99 |
9.3e-04 |
C10orf11 LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Had menopause |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-73O6.3 |
Had other major operations |
1.61 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
PPA2 |
Forced vital capacity (FVC) |
11.84 |
144 |
121 |
268.9 |
0.98 |
6.0e-110 |
ABHD12 AC073834.3 AC083843.1 AC103965.1 ACP2 ADCY3 AHI1 ANGPTL1 AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK BTBD1 C10orf11 C1QTNF4 C4orf14 C6orf106 C6orf126 CACFD1 CCDC87 CD79B CDC123 CDKN2C CDO1 CENPW CEP120 CLUAP1 CNPY2 COQ10A CRIPAK CTA-85E5.10 CTB-36H16.2 CTC-542B22.2 CTD-3076O17.1 CTNNB1 CTSS CYB561 DARS DCAF16 DHDDS DIRAS3 DLEU2 DNAJC9-AS1 EBPL EEF1G EFEMP1 ERCC6L2 FAM136A FAM26F FER FHL3 GALNT12 GDF5 GOLGA6L5 GSDMC GSK3A GSTCD H1FX H6PD HHIP-AS1 HTR4 ICAM2 IGHMBP2 IPO8 JAG1 KIAA1614 LOC147727 LONRF2 LOXL1-AS1 LRPAP1 LRRC37A LRRC37A2 MAPK13 MDM4 MICAL3 MRPL42 MST1P2 MXD3 NFAT5 NOB1 NOSTRIN NSFP1 NUDT5 OTUD4 PAN2 PCDHB5 PLEKHM1P PNKD PPA2 PPIAL4C PSMA4 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RNF123 RP11-196G11.2 RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-967K21.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SEC24C SERPINF1 SLMAP SMARCD2 SMPD2 SNAI3-AS1 TCP11L1 TMED6 TP53INP2 TPD52L2 TRA2A TRIM38 TRIM63 TSEN15 TSPY26P TULP4 U91328.21 UBXN2A WHAMM WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF438 ZNF500 ZNF76 ZSCAN2 |
Heel bone mineral density (BMD) T-score, automated (right) |
2.59 |
15 |
9 |
20.0 |
-0.22 |
3.8e-01 |
ACP2 ARHGAP1 C4orf14 CRIPAK DLEU2 EBPL ERI1 FAM66A FHL3 HHIP-AS1 IGHMBP2 SAPS3 WNT4 ZBTB38 ZNF438 |
Ever unenthusiastic/disinterested for a whole week |
1.34 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LRRC37A LRRC37A2 WNT3 |
Qualifications: None of the above |
1.48 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
PPA2 RAB5B RNF123 |
Mouth/teeth dental problems |
1.04 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
WNT3 |
Allergy |
1.68 |
8 |
4 |
8.9 |
0.80 |
9.0e-03 |
AHI1 C6orf106 CNPY2 RAB5B SEC24C SLC22A4 TPD52L2 ZBTB38 |
Diabetes (self-reported) |
1.72 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C1GALT1 CLUAP1 |
Fluid intelligence score |
1.94 |
5 |
1 |
2.2 |
0.80 |
1.7e-02 |
C1QTNF4 DCAF16 PPA2 RNF123 U91328.21 |
Neuroticism score |
2.28 |
9 |
7 |
15.6 |
-0.38 |
3.1e-01 |
C1QTNF4 ERI1 FAM66A FBXO38 LRRC37A LRRC37A2 RP11-196G11.2 RP11-669E14.6 WNT3 |
Weight |
4.23 |
58 |
38 |
84.4 |
0.76 |
4.7e-14 |
ABHD12 AC103965.1 AP3B1 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CEP120 CRIPAK CTD-3076O17.1 CTNNB1 DCAF16 DLEU2 EBPL EFEMP1 ERI1 FAM66A GDF5 GIPC2 GOLGA6L4 GOLGA6L5 H1FX HHIP-AS1 HTR4 IGHMBP2 LOC147727 MRPL42 MXD3 OTUD4 PPA2 PSMC5 RAB24 RAB5B RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 RPL10A SAPS3 SCMH1 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TPD52L2 TRA2A TRIM38 TRIM63 TSEN15 WNT4 ZBTB38 ZCCHC24 ZNF500 ZNF76 ZSCAN2 |
Impedance of arm (right) |
2.58 |
33 |
28 |
62.2 |
0.16 |
3.5e-01 |
AC083843.1 AC103965.1 AOC1 ARL17A C5orf34 CD79B CENPW CEP120 CTD-3076O17.1 EEF1G EFEMP1 ERI1 FAM66A FER GOLGA6L4 GOLGA6L5 H6PD IGHMBP2 LOXL1-AS1 LRRC37A2 MRPL42 MST1P2 NSFP1 PSMC5 RAB5B RIN3 RP11-669E14.6 RP11-73O6.3 RPL10A SAPS3 SCMH1 WNT3 ZSCAN2 |
Arm fat percentage (right) |
2.84 |
27 |
13 |
28.9 |
-0.64 |
1.1e-04 |
ABHD12 ACP2 ADCY3 AP3B1 ARFGEF2 ARL17A C1QTNF4 C6orf106 CCDC87 CD79B CENPW DCAF16 EEF1G ERI1 FAM66A HTR4 MAPK13 NFAT5 NOB1 NSFP1 PSMC3 PSMC5 RP11-196G11.2 RP11-78I14.1 SYNM TPD52L2 ZNF76 |
Trunk fat-free mass |
7.34 |
78 |
65 |
144.4 |
0.92 |
4.1e-39 |
AC083843.1 ACP2 ADCY3 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 C6orf126 CD79B CDKN2C CENPW CEP120 CNPY2 COQ10A CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM136A FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 ICAM2 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MST1P2 MXD3 NOSTRIN OTUD4 PAN2 PLEKHM1P PNKD PPA2 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Hip circumference |
3.52 |
40 |
29 |
64.4 |
0.45 |
1.6e-03 |
AC103965.1 ACP2 ADCY3 AP3B1 BOK C1QTNF4 C6orf106 CD79B CDKN2C CEP120 CTNNB1 DLEU2 EBPL EFEMP1 ERI1 FAM66A GDF5 GIPC2 GOLGA6L4 H1FX HHIP-AS1 HTR4 LOC147727 NOB1 OTUD4 PSMC3 RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 RPL10A SCMH1 SMPD2 TP53INP2 TPD52L2 TRIM38 WNT4 ZBTB38 ZNF500 ZSCAN2 |
Time employed in main current job |
1.32 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
LRRC37A2 RP11-669E14.6 WNT3 |
Father's age at death |
1.46 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
BTBD1 ERI1 PSMA4 |
Worrier / anxious feelings |
1.90 |
6 |
5 |
11.1 |
-0.17 |
7.5e-01 |
ERI1 FAM66A LRRC37A2 RP11-196G11.2 RP11-669E14.6 WNT3 |
Frequency of tiredness / lethargy in last 2 weeks |
1.42 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC87 |
Hair/balding pattern: Pattern 3 |
2.59 |
5 |
5 |
11.1 |
0.74 |
1.5e-01 |
CENPW LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Number of live births |
1.26 |
4 |
1 |
2.2 |
-0.98 |
2.0e-02 |
LRRC37A LRRC37A2 WNT3 WNT4 |
Forced expiratory volume in 1-second (FEV1) |
13.05 |
166 |
142 |
315.6 |
1.00 |
2.3e-196 |
ABHD12 AC073834.3 AC083843.1 AC103965.1 ACP2 ADAM19 ADCY3 ADO AHI1 ANGPTL1 AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK BTBD1 C10orf11 C1GALT1 C1QTNF4 C4orf14 C5orf34 C6orf106 C6orf126 CACFD1 CARS2 CCDC87 CD79B CDC123 CDKN2C CDO1 CENPW CEP120 CLUAP1 CNPY2 COQ10A CRIPAK CTA-85E5.10 CTB-36H16.2 CTC-542B22.2 CTD-3076O17.1 CTNNB1 CTSS CYB561 DARS DCAF16 DENND2D DHDDS DIRAS3 DLEU2 DNAJC9-AS1 DNALI1 EBPL EEF1G EFEMP1 ERCC6L2 ERI1 FAM136A FAM168A FAM26F FAM66A FBXO38 FER FHL3 GALNT12 GDF5 GIPC2 GM2A GOLGA6L4 GOLGA6L5 GSDMC GSK3A GSTCD H1FX H6PD HESX1 HHIP-AS1 HTR4 ICAM2 IGHMBP2 IPO8 JAG1 KIAA1614 LOC147727 LONRF2 LOXL1-AS1 LRPAP1 LRRC37A LRRC37A2 MAPK13 MDM4 METAP2 MICAL3 MRPL42 MST1P2 MXD3 NFAT5 NOB1 NOC3L NOSTRIN NSFP1 NUDT5 OTUD4 PCDHB5 PCGF2 PLEKHM1P PNKD PPA2 PPIAL4C PSMA4 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RNF123 RP11-196G11.2 RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-967K21.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE2 SCUBE3 SEC24C SERPINF1 SLC22A4 SLMAP SMARCD2 SMPD2 SNAI3-AS1 SOGA2 SYNM TCP11L1 THSD4 TMED6 TP53INP2 TPD52L2 TRA2A TRIM38 TRIM63 TSEN15 TSPY26P TULP4 U91328.21 UBXN2A WHAMM WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF438 ZNF500 ZNF76 ZSCAN2 |
Pulse rate |
1.31 |
4 |
2 |
4.4 |
-0.06 |
9.4e-01 |
CEP120 CTNNB1 EEF1G ZBTB38 |
Qualifications: A levels/AS levels or equivalent |
1.33 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
GDF5 RNF123 |
Mouth/teeth dental problems: Dentures |
1.22 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
ERI1 PSMA4 TRIM38 |
Asthma |
2.53 |
11 |
7 |
15.6 |
-0.94 |
1.5e-06 |
ADAM19 AHI1 CNPY2 HTR4 RAB5B SCUBE3 SLC22A4 TPD52L2 TRIM38 U91328.21 ZNF76 |
Medication: Ibuprofen (e.g. Nurofen) |
1.26 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
U91328.21 |
Medication: Cholesterol lowering |
1.28 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
LOC147727 RP11-196G11.2 |
Lung cancer (father) |
1.52 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PSMA4 |
Impedance of arm (left) |
2.53 |
32 |
26 |
57.8 |
0.26 |
1.2e-01 |
AC103965.1 AOC1 ARL17A CD79B CENPW CEP120 CTD-3076O17.1 EEF1G EFEMP1 ERI1 FAM66A FER GOLGA6L4 GOLGA6L5 H6PD IGHMBP2 LOXL1-AS1 LRRC37A LRRC37A2 MRPL42 MST1P2 NSFP1 PSMC5 RAB5B RIN3 RP11-669E14.6 RP11-73O6.3 SAPS3 SCMH1 TSPY26P WNT3 ZSCAN2 |
Arm fat mass (right) |
2.54 |
24 |
15 |
33.3 |
-0.13 |
5.1e-01 |
ABHD12 ACP2 ADCY3 AP3B1 C1QTNF4 C6orf106 CCDC87 CEP120 CTNNB1 ERI1 FAM66A HTR4 NOB1 OTUD4 PSMC3 RAB5B RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 TP53INP2 TPD52L2 TRIM38 ZBTB38 ZNF500 |
Trunk predicted mass |
7.34 |
78 |
65 |
144.4 |
0.92 |
4.2e-39 |
AC083843.1 ACP2 ADCY3 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 C6orf126 CD79B CDKN2C CENPW CEP120 CNPY2 COQ10A CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM136A FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 ICAM2 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MST1P2 MXD3 NOSTRIN OTUD4 PAN2 PLEKHM1P PNKD PPA2 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Standing height |
9.96 |
113 |
103 |
228.9 |
0.91 |
1.8e-51 |
AC083843.1 AC103965.1 ACP2 ADCY3 ADO AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK C1QTNF4 C4orf14 C6orf106 C6orf126 CACFD1 CCDC87 CD79B CDKN2C CDO1 CENPW CEP120 CNPY2 COQ10A CRIPAK CTC-542B22.2 CTD-3076O17.1 CTNNB1 CYB561 DCAF16 DHDDS DLEU2 DNALI1 EBPL EFEMP1 ERCC6L2 ERI1 FAM136A FAM26F FAM66A FER FHL3 GDF5 GIPC2 GOLGA6L4 GOLGA6L5 GSDMC GSK3A H1FX H6PD HHIP-AS1 ICAM2 IGHMBP2 IPO8 JAG1 KIAA1614 LOC147727 LOXL1-AS1 LRRC37A2 MRPL42 MST1P2 MXD3 NFAT5 NOB1 NOC3L NOSTRIN NSFP1 OTUD4 PAN2 PCDHB5 PLEKHM1P PNKD PPA2 PPIAL4C PSMC3 PSMC5 QSOX2 RAB24 RAD9A RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TMED6 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 U91328.21 UBXN2A WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 ZSCAN2 |
Tense / 'highly strung' |
1.48 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ERI1 FAM66A RP11-196G11.2 |
Seen doctor (GP) for nerves, anxiety, tension or depression |
1.56 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC87 U91328.21 |
Hair/balding pattern: Pattern 4 |
4.16 |
10 |
9 |
20.0 |
0.35 |
3.2e-01 |
C10orf11 CENPW CTB-36H16.2 CTNNB1 FAM136A LRRC37A LRRC37A2 RP11-669E14.6 WNT3 ZBTB38 |
Birth weight of first child |
2.96 |
14 |
7 |
15.6 |
0.95 |
5.7e-08 |
ARFGEF2 ASPSCR1 C6orf126 DCAF16 IPO8 MAPK13 NOC3L OTUD4 PPA2 RP11-78I14.1 RPL10A WNT4 ZBTB38 ZNF76 |
Peak expiratory flow (PEF) |
7.24 |
58 |
33 |
73.3 |
0.97 |
4.2e-39 |
ADAM19 ARFGEF2 ARL17A ASPSCR1 BOK BTBD1 C10orf11 C1GALT1 C4orf14 C6orf106 CACFD1 CCDC87 CD79B CDC123 CDKN2C CTA-85E5.10 DCAF16 DHDDS DLEU2 DNALI1 EBPL EFEMP1 ERI1 FAM168A FAM66A FBXO38 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 HTR4 LOC147727 LOXL1-AS1 LRRC37A LRRC37A2 MDM4 METAP2 NOSTRIN NUDT5 OTUD4 PCGF2 PNKD PPA2 PSMC5 RAD9A RNF123 RP11-669E14.6 RPL10A SAPS3 SMPD2 THSD4 TP53INP2 TRIM63 UBXN2A WNT3 ZHX2 ZNF76 |
Blood clot in the leg (DVT) |
1.43 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CACFD1 |
Medication: Paracetamol |
1.84 |
5 |
5 |
11.1 |
-0.70 |
1.9e-01 |
LRRC37A LRRC37A2 RP11-669E14.6 U91328.21 WNT3 |
Headache pain in last month |
1.92 |
6 |
5 |
11.1 |
-0.60 |
2.1e-01 |
LRRC37A LRRC37A2 RAB5B RP11-669E14.6 U91328.21 WNT3 |
Medication for cholesterol, blood pressure or diabetes |
1.39 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TSPY26P |
Gout (self-reported) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
U91328.21 |
Hypothyroidism/myxoedema (self-reported) |
1.56 |
5 |
4 |
8.9 |
0.11 |
8.6e-01 |
AHI1 ERI1 FAM66A RAB5B ZNF76 |
Medication: Ventolin 100micrograms inhaler |
1.67 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RAB5B |
Birth weight |
2.62 |
13 |
3 |
6.7 |
0.80 |
5.3e-04 |
C1QTNF4 C6orf126 CENPW CEP120 DCAF16 MAPK13 PPA2 RP11-73O6.3 TRA2A TULP4 UBXN2A WNT4 ZNF76 |
Chronic bronchitis/emphysema (mother) |
1.69 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
HHIP-AS1 PSMA4 |
High blood pressure (siblings) |
1.49 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-196G11.2 |
Forced vital capacity (FVC), Best measure |
12.44 |
149 |
124 |
275.6 |
0.98 |
2.0e-115 |
ABHD12 AC073834.3 AC083843.1 AC103965.1 ACP2 ADCY3 ADO AHI1 ANGPTL1 AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK BTBD1 C10orf11 C1GALT1 C1QTNF4 C4orf14 C5orf34 C6orf106 C6orf126 CACFD1 CARS2 CCDC87 CD79B CDC123 CDKN2C CDO1 CENPW CEP120 CLUAP1 CNPY2 COQ10A CRIPAK CTA-85E5.10 CTB-36H16.2 CTC-542B22.2 CTD-3076O17.1 CTNNB1 CTSS CYB561 DARS DCAF16 DHDDS DIRAS3 DLEU2 DNAJC9-AS1 DNALI1 EBPL EEF1G EFEMP1 ERCC6L2 FAM136A FAM26F FER FHL3 GALNT12 GDF5 GOLGA6L5 GSDMC GSK3A GSTCD H1FX H6PD HHIP-AS1 HTR4 ICAM2 IGHMBP2 IPO8 JAG1 KIAA1614 LOC147727 LONRF2 LOXL1-AS1 LRPAP1 LRRC37A LRRC37A2 MAPK13 MDM4 MICAL3 MRPL42 MST1P2 MXD3 NFAT5 NOB1 NOC3L NOSTRIN NSFP1 NUDT5 OTUD4 PAN2 PCDHB5 PLEKHM1P PNKD PPA2 PPIAL4C PSMA4 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RNF123 RP11-196G11.2 RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-967K21.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE2 SCUBE3 SEC24C SERPINF1 SMARCD2 SMPD2 SNAI3-AS1 TCP11L1 TMED6 TP53INP2 TPD52L2 TRA2A TRIM38 TRIM63 TSEN15 TULP4 U91328.21 UBXN2A WHAMM WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF438 ZNF500 ZNF76 ZSCAN2 |
Body fat percentage |
3.10 |
33 |
20 |
44.4 |
-0.37 |
2.0e-02 |
ABHD12 AC073834.3 AC103965.1 ACP2 ADCY3 AP3B1 ARFGEF2 C1QTNF4 C6orf106 CD79B CENPW CTD-3076O17.1 DARS DCAF16 EEF1G ERI1 GOLGA6L4 GOLGA6L5 GSK3A HTR4 MAPK13 NOB1 PSMC3 PSMC5 RIN3 RP11-196G11.2 RP11-78I14.1 SYNM TPD52L2 TRIM38 ZBTB38 ZNF500 ZSCAN2 |
Leg fat percentage (right) |
2.97 |
29 |
17 |
37.8 |
-0.70 |
3.0e-06 |
ABHD12 AC073834.3 ACP2 ADCY3 ARFGEF2 C1QTNF4 C6orf106 CD79B CENPW DARS DCAF16 ERI1 GDF5 GOLGA6L4 GSK3A HTR4 MAPK13 NOB1 PLEKHM1P PSMC3 PSMC5 RIN3 RP11-196G11.2 SMARCD2 SNAI3-AS1 SYNM TPD52L2 TRIM38 ZSCAN2 |
Arm fat-free mass (right) |
6.13 |
66 |
54 |
120.0 |
0.91 |
1.6e-30 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PAN2 PNKD PPA2 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 UBXN2A ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Comparative body size at age 10 |
2.66 |
13 |
7 |
15.6 |
-0.53 |
3.4e-02 |
ACP2 ADCY3 AP3B1 ARL17A C1QTNF4 ERI1 FAM66A GOLGA6L4 NSFP1 PSMC3 RP11-196G11.2 SAPS3 U91328.21 |
Worry too long after embarrassment |
1.75 |
6 |
0 |
0.0 |
0.05 |
9.2e-01 |
AHI1 ERI1 FAM66A PPA2 RP11-669E14.6 WNT3 |
Wheeze or whistling in the chest in last year |
2.07 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM19 CTC-542B22.2 TPD52L2 |
Health satisfaction |
1.25 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC87 |
Qualifications: College or University degree |
1.62 |
11 |
7 |
15.6 |
0.76 |
4.1e-03 |
EEF1G GDF5 LRRC37A LRRC37A2 MDM4 PPA2 RAB5B RNF123 RP11-669E14.6 SMARCD2 WNT3 |
Medication for pain relief, constipation, heartburn |
1.71 |
5 |
4 |
8.9 |
0.56 |
3.3e-01 |
LRRC37A LRRC37A2 RP11-669E14.6 U91328.21 WNT3 |
Medication: Blood pressure |
1.59 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ERI1 TSPY26P |
Medication: Seretide 50 evohaler |
1.57 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC22A4 |
Mean time to correctly identify matches |
1.73 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARL17A NSFP1 SCUBE2 |
Whole body fat mass |
2.97 |
32 |
25 |
55.6 |
0.21 |
2.0e-01 |
ABHD12 AC103965.1 ACP2 ADCY3 AP3B1 C1QTNF4 C6orf106 CEP120 CTD-3076O17.1 CTNNB1 EFEMP1 ERI1 GDF5 GOLGA6L4 GOLGA6L5 H1FX HTR4 MAPK13 NOB1 OTUD4 PSMC3 RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 SYNM TP53INP2 TPD52L2 TRIM38 ZBTB38 ZNF500 ZSCAN2 |
Leg fat mass (right) |
2.56 |
27 |
14 |
31.1 |
-0.03 |
8.7e-01 |
ABHD12 ACP2 ADCY3 AP3B1 C1QTNF4 C6orf106 CTNNB1 DARS ERI1 FAM66A GIPC2 GOLGA6L4 GOLGA6L5 HTR4 NOB1 OTUD4 PSMC3 RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 SYNM TPD52L2 TRIM38 ZBTB38 ZNF500 ZSCAN2 |
Arm predicted mass (right) |
6.07 |
66 |
52 |
115.6 |
0.91 |
1.8e-29 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PNKD PPA2 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 UBXN2A WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Pulse rate, automated reading |
1.65 |
12 |
6 |
13.3 |
-0.52 |
5.4e-02 |
AC103965.1 BTBD1 C6orf106 CEP120 CTNNB1 DARS EEF1G PCGF2 RAB5B RP11-382A20.2 TRIM63 ZBTB38 |
Alcohol intake frequency. |
1.77 |
9 |
8 |
17.8 |
-0.97 |
1.4e-06 |
C1QTNF4 LRRC37A LRRC37A2 PPA2 PSMC3 RP11-669E14.6 TMED6 UBXN2A WNT3 |
Comparative height size at age 10 |
8.38 |
85 |
67 |
148.9 |
0.90 |
8.0e-38 |
AC103965.1 ACP2 ADCY3 AOC1 AP3B1 ARFGEF2 ARHGAP1 ARL17A ASPSCR1 BOK C1QTNF4 C6orf106 CD79B CDKN2C CDO1 CENPW CEP120 CRIPAK CTD-3076O17.1 CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM136A FAM26F FER FHL3 GDF5 GOLGA6L4 GOLGA6L5 GSDMC H1FX H6PD HHIP-AS1 ICAM2 IPO8 KIAA1614 LOC147727 LOXL1-AS1 LRRC37A2 MICAL3 MRPL42 MST1P2 MXD3 NSFP1 OTUD4 PLEKHM1P PNKD PPA2 PPIAL4C PSMC3 PSMC5 QSOX2 RAB24 RAD9A RP11-250B2.6 RP11-669E14.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 U91328.21 UBXN2A WNT3 WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 ZSCAN2 |
Suffer from 'nerves' |
1.81 |
2 |
1 |
2.2 |
0.99 |
1.0e-02 |
C1QTNF4 FAM66A |
Overall health rating |
1.58 |
6 |
2 |
4.4 |
-0.69 |
1.3e-01 |
C6orf106 CCDC87 DCAF16 ERI1 HTR4 RP11-196G11.2 |
Leg pain on walking |
1.25 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
WNT3 |
Knee pain experienced in last month |
1.71 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
GDF5 LOC147727 RP11-196G11.2 |
Hypertension (Self-reported) |
1.81 |
14 |
6 |
13.3 |
-0.86 |
3.6e-05 |
ACP2 ADO ARFGEF2 ARHGAP1 C1GALT1 DCAF16 ERI1 FAM66A HTR4 RP11-196G11.2 RP11-538P18.2 SLC22A4 TSPY26P U91328.21 |
Forced expiratory volume in 1-second (FEV1), predicted |
7.65 |
48 |
33 |
73.3 |
0.97 |
2.5e-37 |
AC103965.1 ACP2 ADCY3 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CNPY2 CTD-3076O17.1 DCAF16 DLEU2 EBPL EFEMP1 FER GDF5 GOLGA6L4 GOLGA6L5 GSDMC H1FX HHIP-AS1 LOC147727 MRPL42 MST1P2 NOSTRIN OTUD4 PAN2 PSMC3 PSMC5 RAB24 RAD9A RP11-690I21.1 RP11-73O6.3 RP11-977G19.11 RPL10A SCMH1 SCUBE3 SLC22A4 SMARCD2 TP53INP2 TRA2A TSEN15 ZBTB38 ZHX2 ZNF500 ZNF76 ZSCAN2 |
Whole body fat-free mass |
6.56 |
72 |
60 |
133.3 |
0.92 |
3.4e-35 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 COQ10A CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PAN2 PLEKHM1P PNKD PPA2 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Leg fat-free mass (right) |
5.39 |
61 |
49 |
108.9 |
0.90 |
4.0e-27 |
AC083843.1 AOC1 AP3B1 BOK C6orf106 CD79B CDKN2C CENPW CEP120 CRIPAK CTNNB1 DCAF16 DLEU2 EBPL EFEMP1 ERI1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PLEKHM1P PNKD PPA2 PSMC5 QSOX2 RAB5B RAD9A RIN3 RP11-250B2.6 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZNF500 ZNF76 |
Arm fat percentage (left) |
2.94 |
25 |
14 |
31.1 |
-0.69 |
3.6e-05 |
ABHD12 ACP2 ADCY3 AP3B1 ARFGEF2 C1QTNF4 C6orf106 CCDC87 CD79B CENPW DCAF16 ERI1 FAM66A HTR4 MAPK13 NFAT5 NOB1 PSMC3 PSMC5 RP11-196G11.2 RP11-78I14.1 SYNM TPD52L2 TRIM38 ZNF76 |
Handedness (chirality/laterality): Left-handed |
1.70 |
5 |
3 |
6.7 |
0.97 |
4.9e-03 |
ARL17A LRRC37A2 NSFP1 RP11-669E14.6 WNT3 |
Mood swings |
1.86 |
5 |
5 |
11.1 |
-0.99 |
1.0e-03 |
FBXO38 LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Loneliness, isolation |
1.52 |
3 |
1 |
2.2 |
0.66 |
2.2e-01 |
C1QTNF4 LRRC37A2 WNT3 |
Long-standing illness, disability or infirmity |
1.31 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NOB1 |
Diabetes diagnosed by doctor |
1.80 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
C1GALT1 CENPW NOB1 |
Mouth/teeth dental problems: Mouth ulcers |
1.68 |
5 |
5 |
11.1 |
-0.78 |
1.2e-01 |
CTSS LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Mineral and other dietary supplements |
1.29 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NFAT5 |
Asthma (self-reported) |
2.48 |
10 |
7 |
15.6 |
-0.94 |
5.5e-06 |
ADAM19 AHI1 CNPY2 HTR4 RAB5B SCUBE3 SLC22A4 TRIM38 U91328.21 ZNF76 |
Osteoporosis (self-reported) |
1.52 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SAPS3 |
Osteoarthritis (self-reported) |
1.26 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
LOC147727 |
Smoking status: Current |
1.44 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
C1QTNF4 |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
7.02 |
54 |
31 |
68.9 |
0.98 |
7.8e-39 |
ABHD12 AC073834.3 ADAM19 ANGPTL1 ASPSCR1 BOK BTBD1 C10orf11 CDC123 CEP120 CLUAP1 CTA-85E5.10 CTSS DHDDS EEF1G ERI1 FAM168A FAM66A FBXO38 GSTCD HHIP-AS1 HTR4 JAG1 LRRC37A LRRC37A2 MICAL3 NOB1 NUDT5 PCGF2 PPA2 PSMA4 QSOX2 RIN3 RNF123 RP11-196G11.2 RP11-250B2.6 RP11-382A20.2 RP11-538P18.2 RP11-669E14.6 RP11-967K21.1 RPL10A SEC24C SLMAP SMPD2 SOGA2 THSD4 TPD52L2 TRIM38 TRIM63 U91328.21 WHAMM WNT3 WNT4 ZNF76 |
Whole body water mass |
6.53 |
72 |
61 |
135.6 |
0.92 |
3.2e-35 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 COQ10A CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PAN2 PLEKHM1P PNKD PPA2 PSMC3 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Leg predicted mass (right) |
5.40 |
62 |
49 |
108.9 |
0.90 |
1.9e-27 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C6orf106 CD79B CDKN2C CENPW CEP120 CRIPAK CTNNB1 DCAF16 DLEU2 EBPL EFEMP1 ERI1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PLEKHM1P PNKD PPA2 PSMC5 QSOX2 RAB5B RAD9A RIN3 RP11-250B2.6 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SLC22A4 SMARCD2 SMPD2 SNAI3-AS1 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZNF500 ZNF76 |
Arm fat mass (left) |
2.57 |
27 |
16 |
35.6 |
-0.03 |
8.6e-01 |
ABHD12 ACP2 ADCY3 AP3B1 C1QTNF4 C6orf106 CCDC87 CEP120 CTNNB1 ERI1 FAM66A GDF5 GOLGA6L4 HTR4 NOB1 OTUD4 PSMC3 RAB5B RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 TP53INP2 TPD52L2 TRIM38 ZBTB38 ZNF500 |
Number of self-reported non-cancer illnesses |
1.59 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC87 SLC22A4 |
Average weekly champagne plus white wine intake |
1.34 |
4 |
0 |
0.0 |
0.99 |
1.0e-02 |
LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Miserableness |
1.60 |
6 |
5 |
11.1 |
-0.56 |
2.5e-01 |
ERI1 FAM66A LRRC37A LRRC37A2 RP11-669E14.6 WNT3 |
Guilty feelings |
1.72 |
6 |
0 |
0.0 |
-0.76 |
7.9e-02 |
CNPY2 LRRC37A LRRC37A2 RP11-669E14.6 UBXN2A WNT3 |
Medication: Blood pressure |
1.72 |
5 |
2 |
4.4 |
0.05 |
9.3e-01 |
C1GALT1 ERI1 FAM66A LRRC37A2 RP11-669E14.6 |
Supplements: Fish oil (including cod liver oil) |
1.43 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CCDC87 NFAT5 |
High cholesterol (Self-reported) |
1.37 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
FAM136A LOC147727 RP11-196G11.2 |
Medication: Bendroflumethiazide |
1.49 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
ERI1 FAM66A |
Medication: Paracetamol |
1.73 |
5 |
4 |
8.9 |
-0.78 |
1.2e-01 |
LRRC37A LRRC37A2 RP11-669E14.6 U91328.21 WNT3 |
Ever smoked |
1.47 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C4orf14 PSMA4 |
Basal metabolic rate |
6.00 |
69 |
53 |
117.8 |
0.90 |
4.0e-31 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PAN2 PNKD PPA2 PSMC5 QSOX2 RAB24 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 TULP4 UBXN2A WNT4 ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 ZSCAN2 |
Leg fat percentage (left) |
2.97 |
31 |
17 |
37.8 |
-0.69 |
2.7e-06 |
ABHD12 AC073834.3 ACP2 ADCY3 ARFGEF2 C1QTNF4 C6orf106 CD79B CENPW DARS DCAF16 ERI1 GDF5 GIPC2 GOLGA6L4 GSK3A HTR4 MAPK13 NOB1 PLEKHM1P PSMC3 PSMC5 RIN3 RP11-196G11.2 SMARCD2 SYNM TPD52L2 TRIM38 UBXN2A ZNF76 ZSCAN2 |
Arm fat-free mass (left) |
5.94 |
66 |
51 |
113.3 |
0.90 |
1.8e-29 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C1QTNF4 C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PAN2 PNKD PPA2 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 UBXN2A ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |
Number of operations (self-reported) |
1.69 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
PPA2 |
Average weekly beer plus cider intake |
1.61 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RNF123 |
Irritability |
1.76 |
7 |
5 |
11.1 |
-0.33 |
4.6e-01 |
ERI1 FAM66A LRRC37A LRRC37A2 RP11-196G11.2 RP11-669E14.6 WNT3 |
Ever had prostate specific antigen (PSA) test |
1.41 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ZBTB38 |
Fractured/broken bones in last 5 years |
1.49 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
CRIPAK WNT3 |
Diastolic blood pressure, automated reading |
2.09 |
16 |
11 |
24.4 |
-0.17 |
5.2e-01 |
ADO BTBD1 CEP120 CTNNB1 DARS DCAF16 ERI1 FAM66A JAG1 MICAL3 RP11-538P18.2 SCMH1 SLMAP THSD4 U91328.21 ZNF76 |
Myopia |
1.95 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACP2 QSOX2 |
Vascular/heart problems diagnosed by doctor |
1.73 |
12 |
7 |
15.6 |
0.85 |
2.2e-04 |
ACP2 ADO ARHGAP1 C1GALT1 DCAF16 ERI1 FAM66A NFAT5 RP11-196G11.2 RP11-538P18.2 SLC22A4 TSPY26P |
Cholesterol lowering medication |
1.48 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP11-196G11.2 |
Pain experienced in last month |
1.54 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
CENPW RP11-196G11.2 RP11-669E14.6 |
Deep venous thrombosis (DVT) (self-reported) |
1.37 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CACFD1 |
Heart disease (siblings) |
1.29 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TP53INP2 |
Pack years of smoking |
2.44 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CYB561 PSMA4 |
Impedance of whole body |
2.78 |
39 |
27 |
60.0 |
0.13 |
4.3e-01 |
AC083843.1 AC103965.1 ADCY3 AOC1 C5orf34 CD79B CENPW CEP120 CTD-3076O17.1 EEF1G EFEMP1 ERI1 FAM66A GDF5 GOLGA6L4 GOLGA6L5 H6PD IGHMBP2 LOXL1-AS1 LRRC37A LRRC37A2 MRPL42 MST1P2 NSFP1 OTUD4 PPA2 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-382A20.2 RP11-669E14.6 RP11-73O6.3 SAPS3 SCMH1 SMPD2 WNT3 ZSCAN2 |
Leg fat mass (left) |
2.51 |
27 |
15 |
33.3 |
-0.03 |
8.5e-01 |
ABHD12 ACP2 ADCY3 AP3B1 C1QTNF4 C6orf106 DARS ERI1 FAM66A GIPC2 GOLGA6L4 GOLGA6L5 HTR4 NOB1 OTUD4 PSMC3 RAB5B RAD9A RP11-196G11.2 RP11-73O6.3 RP11-78I14.1 SYNM TPD52L2 TRIM38 ZBTB38 ZNF500 ZSCAN2 |
Arm predicted mass (left) |
5.87 |
65 |
50 |
111.1 |
0.90 |
2.1e-28 |
AC083843.1 AOC1 AP3B1 ARFGEF2 BOK C6orf106 CD79B CDKN2C CENPW CEP120 CNPY2 CRIPAK CTNNB1 DCAF16 DHDDS DLEU2 EBPL EFEMP1 FAM66A FHL3 GDF5 GIPC2 GSDMC H1FX HHIP-AS1 IGHMBP2 IPO8 KIAA1614 LOC147727 MRPL42 MXD3 NOSTRIN OTUD4 PAN2 PNKD PPA2 PSMC5 RAB24 RAB5B RAD9A RIN3 RP11-196G11.2 RP11-250B2.6 RP11-690I21.1 RP11-73O6.3 RP11-78I14.1 RP11-977G19.11 RPL10A SAPS3 SCMH1 SCUBE3 SERPINF1 SLC22A4 SMARCD2 SMPD2 TP53INP2 TRA2A TRIM63 TSEN15 UBXN2A ZBTB38 ZCCHC24 ZHX2 ZNF500 ZNF76 |